Medtech Acquisition Corp.
13F holders, Q4 2024 (December 31)2holders +1
1new positions
0sold out
$5.01avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Medtech Acquisition Corp. in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Graypoint LLC ($603K) and JDM Financial Group LLC ($3K).
- Company
- Medtech Acquisition Corp.
- Filed as
- TRISALUS LIFE SCIENCES INC COM (Q4 2024)
- CUSIP
- 58507N105
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $603K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 120,355 shares bought, net +120,355 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Graypoint LLC | 0.04% | New | 120,355 | $603K |
| JDM Financial Group LLC | 0.00% | No change | 530 | $3K |
"% of holder's portfolio" is MEDTECH ACQUISITION CORP's weight in each manager's 13F, not the share of Medtech Acquisition Corp. the manager owns.